These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 34770976)
1. Deep Membrane Proteome Profiling Reveals Overexpression of Prostate-Specific Membrane Antigen (PSMA) in High-Risk Human Paraganglioma and Pheochromocytoma, Suggesting New Theranostic Opportunity. Vit O; Patel M; Musil Z; Hartmann I; Frysak Z; Miettinen M; Pacak K; Petrak J Molecules; 2021 Oct; 26(21):. PubMed ID: 34770976 [TBL] [Abstract][Full Text] [Related]
2. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters. van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126 [TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs). Khatami F; Mohammadamoli M; Tavangar SM Endocr Regul; 2018 Jan; 52(1):41-54. PubMed ID: 29453919 [TBL] [Abstract][Full Text] [Related]
4. Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization. Vit O; Talacko P; Musil Z; Hartmann I; Pacak K; Petrak J Clin Proteomics; 2023 Sep; 20(1):39. PubMed ID: 37749499 [TBL] [Abstract][Full Text] [Related]
5. The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma. Peng S; Zhang J; Tan X; Huang Y; Xu J; Silk N; Zhang D; Liu Q; Jiang J Front Endocrinol (Lausanne); 2020; 11():586857. PubMed ID: 33329393 [TBL] [Abstract][Full Text] [Related]
6. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma. Dong Y; Huang Y; Fan C; Wang L; Zhang R; Li W; Guo Z; Wang D; Zheng Z Cell Death Dis; 2021 May; 12(5):444. PubMed ID: 33947839 [TBL] [Abstract][Full Text] [Related]
7. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients. Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449 [TBL] [Abstract][Full Text] [Related]
8. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma. Taïeb D; Pacak K Cell Tissue Res; 2018 May; 372(2):393-401. PubMed ID: 29450723 [TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Timmers HJ; Gimenez-Roqueplo AP; Mannelli M; Pacak K Endocr Relat Cancer; 2009 Jun; 16(2):391-400. PubMed ID: 19190077 [TBL] [Abstract][Full Text] [Related]
10. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas. Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002 [TBL] [Abstract][Full Text] [Related]
11. LncRNA expression and SDHB mutations in pheochromocytomas and paragangliomas. Li H; Hardin H; Zaeem M; Huang W; Hu R; Lloyd RV Ann Diagn Pathol; 2021 Dec; 55():151801. PubMed ID: 34461576 [TBL] [Abstract][Full Text] [Related]
12. Genetics and imaging of pheochromocytomas and paragangliomas: current update. Katabathina VS; Rajebi H; Chen M; Restrepo CS; Salman U; Vikram R; Menias CO; Prasad SR Abdom Radiol (NY); 2020 Apr; 45(4):928-944. PubMed ID: 31069476 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force. Ku EJ; Kim KJ; Kim JH; Kim MK; Ahn CH; Lee KA; Lee SH; Lee YB; Park KH; Choi YM; Hong N; Hong AR; Kang SW; Park BK; Seong MW; Kim M; Jung KC; Jung CK; Cho YS; Paeng JC; Kim JH; Ryu OH; Rhee Y; Kim CH; Lee EJ Endocrinol Metab (Seoul); 2021 Apr; 36(2):322-338. PubMed ID: 33820394 [TBL] [Abstract][Full Text] [Related]
14. Genetic Characteristics of Incidental Pheochromocytoma and Paraganglioma. Zhang J; Li M; Pang Y; Wang C; Wu J; Cheng Z; Li X; Lu Z; Liu Y; Guo J; Chen X; He Y; Guan X; Xu X; Wang Y; Liu J; Guo W; Hou Y; Liu L; Jiang J; Gao X J Clin Endocrinol Metab; 2022 Apr; 107(5):e1835-e1842. PubMed ID: 35106577 [TBL] [Abstract][Full Text] [Related]
15. Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry. Juhlin CC Endocr Pathol; 2021 Jun; 32(2):228-244. PubMed ID: 33768452 [TBL] [Abstract][Full Text] [Related]
17. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches. Kuo MJM; Nazari MA; Jha A; Pacak K Front Endocrinol (Lausanne); 2022; 13():936178. PubMed ID: 35903274 [TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways. de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872 [TBL] [Abstract][Full Text] [Related]
19. Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma. Murakami M; Sun N; Greunke C; Feuchtinger A; Kircher S; Deutschbein T; Papathomas T; Bechmann N; William Wallace P; Peitzsch M; Korpershoek E; Friemel J; Gimenez-Roqueplo AP; Robledo M; J L M Timmers H; Canu L; Weber A; R de Krijger R; Fassnacht M; Knösel T; Kirchner T; Reincke M; Karl Walch A; Kroiss M; Beuschlein F Eur J Endocrinol; 2021 Jun; 185(1):179-191. PubMed ID: 33983135 [TBL] [Abstract][Full Text] [Related]
20. Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma. Jiang J; Zhang J; Pang Y; Bechmann N; Li M; Monteagudo M; Calsina B; Gimenez-Roqueplo AP; Nölting S; Beuschlein F; Fassnacht M; Deutschbein T; Timmers HJLM; Åkerström T; Crona J; Quinkler M; Fliedner SMJ; Liu Y; Guo J; Li X; Guo W; Hou Y; Wang C; Zhang L; Xiao Q; Liu L; Gao X; Burnichon N; Robledo M; Eisenhofer G J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32750708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]